0001575705-19-000060.txt : 20190515 0001575705-19-000060.hdr.sgml : 20190515 20190515135229 ACCESSION NUMBER: 0001575705-19-000060 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 48 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190515 DATE AS OF CHANGE: 20190515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: POWERVERDE, INC. CENTRAL INDEX KEY: 0000933972 STANDARD INDUSTRIAL CLASSIFICATION: MOTORS & GENERATORS [3621] IRS NUMBER: 880271109 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-27866 FILM NUMBER: 19826963 BUSINESS ADDRESS: STREET 1: 21615 N. 2ND AVENUE CITY: PHOENIX STATE: AZ ZIP: 85027 BUSINESS PHONE: 623-780-3321 MAIL ADDRESS: STREET 1: 21615 N. 2ND AVENUE CITY: PHOENIX STATE: AZ ZIP: 85027 FORMER COMPANY: FORMER CONFORMED NAME: VYREX CORP DATE OF NAME CHANGE: 19951206 10-Q 1 pwvi_1q19.htm FORM 10-Q

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 


 

Form 10-Q

 


 

 ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Quarterly Period ended March 31, 2019

 

 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Commission file number: 000-27866

 


 

POWERVERDE, INC. 

(Exact name of Registrant as specified in its charter)

 


 

Delaware   88-0271109
(State or other jurisdiction of
incorporation or organization)
  (IRS Employer
Identification No.)

 

9300 S. Dadeland Blvd, Suite 600 

Miami, FL 33156

(Address of principal executive offices)

 

(305) 670-3370

(Registrant’s telephone number including area code)

 

(Former name, former address and former fiscal year, if changed since last report)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   ☒   Yes   ☐   No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   ☒   Yes   ☐   No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

 ☐ Large accelerated filer ☐  Accelerated filer
 ☐ Non-accelerated filer ☒  Smaller reporting company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   ☐   Yes   ☒   No

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: As of May 14, 2019, the issuer had 31,750,106 shares of common stock outstanding.

 

i

 

 

Index to Form 10-Q

 

     
    Page
PART I FINANCIAL INFORMATION 1
     
Item 1. Condensed Consolidated Financial Statements (Unaudited) 1
  Condensed Consolidated Balance Sheets at March 31, 2019 (Unaudited)   and December 31, 2018 1
  Condensed Consolidated Statements of Operations for the three months   ended March 31, 2019 and 2018 (Unaudited) 3
  Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity for the three months ended March 31, 2019 and 2018 (Unaudited) 4
  Condensed Consolidated Statements of Cash Flows for the three months   Ended March 31, 2019 and 2018 (Unaudited) 5
  Notes to Unaudited Condensed Consolidated Financial Statements 6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 12
Item 3. Quantitative and Qualitative Disclosures about Market Risk 15
Item 4. Controls and Procedures 15
     
PART II OTHER INFORMATION 16
     
Item 1. Legal Proceedings 16
Item 1A. Risk Factors 16
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 16
Item 3. Defaults upon Senior Securities 16
Item 4. Mine Safety Disclosures 16
Item 5. Other Information 16
Item 6. Exhibits 17
   
SIGNATURES 18

 

Cautionary Note Regarding Forward-Looking Information

 

This Form 10-Q contains certain statements related to future results of the Company that are considered “forward-looking statements” within the meaning of the Private Litigation Reform Act of 1995. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties, including, but not limited to, changes in political and economic conditions; interest rate fluctuation; competitive pricing pressures within the Company’s market; equity and fixed income market fluctuation; technological changes; changes in law; changes in fiscal, monetary, regulatory, and tax policies; monetary fluctuations as well as other risks and uncertainties detailed elsewhere in this Form 10-Q or from time-to-time in the filings of the Company with the Securities and Exchange Commission. Such forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events.

 

ii

 

 

PART I FINANCIAL INFORMATION

 

Item 1. Condensed Consolidated Financial Statements

 

PowerVerde, Inc. and Subsidiary
Condensed Consolidated Balance Sheets
March 31, 2019 (Unaudited) and December 31, 2018

 

   2019  2018
Assets          
Current Assets:          
Cash and cash equivalents  $218,143   $8,482 
Accounts receivable   5,000    10,000 
Prepaid expenses and other current assets   15,574    10,866 
Total Current Assets   238,717    29,348 
           
Property and Equipment          
Property and equipment, net of accumulated depreciation of $107,641 and $107,007, respectively       634 
           
Other Assets          
License, net of accumulated amortization of $28,322 and $25,822,   respectively   71,678    74,178 
Total Other Assets   71,678    74,178 
Total Assets  $310,395   $104,160 
           
Liabilities and Stockholders’ (Deficit) Equity          
Current Liabilities          
Accounts payable and accrued expenses  $72,801   $39,136 
Total Current Liabilities   72,801    39,136 
           
Long Term Liabilities          
Note Payable to related parties, net of loan costs   267,721     
Total Long Term Liabilities   267,721     
           
Total Liabilities   340,522    39,136 

    
Stockholders’ Equity (Deficit)          
Preferred Stock:          
50,000,000 preferred shares authorized, 0 preferred shares issued   at March 31, 2019 and December 31, 2018        
Common stock:          
  200,000,000 common shares authorized, par value $0.0001 per share, 40,300,106 common shares issued and 31,750,106 shares outstanding at March 31, 2019 and December 31, 2018   3,981    3,981 
Additional paid-in capital   12,609,980    12,609,980 
Treasury stock, 8,550,000 shares at cost   (491,139)   (491,139)
Accumulated deficit   (12,152,949)   (12,057,798)
Total Stockholders’ (Deficit) Equity   (30,127)   65,024 
           
Total Liabilities and Stockholders’ Equity (Deficit)  $310,395   $104,160 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

1

 

 

PowerVerde, Inc. and Subsidiary
Condensed Consolidated Statements of Operations
For the three months ended March 31, 2019 and 2018
(Unaudited
)

 

   2019  2018
       
Revenue  $5,000   $162,094 
           
Operating Expenses          
Research and development   35,059    35,292 
General and administrative   60,798    70,394 
Total Operating Expenses   95,857    105,686 
           
(Loss) Income from Operations   (90,857)   56,408 
           
Other Income (Expenses)          
Interest income       914 
Interest expense   (4,294)   (698)
Total Other (Expense) Income   (4,294)   216 
           
(Loss) Income before Income Taxes   (95,151)   56,624 
Provision for Income Taxes        
           
Net (Loss) Income  $(95,151)  $56,624 
           
Net (Loss) Income per Share - Basic and Diluted  $0.00   $0.00 
           
Weighted Average Common Shares Outstanding - Basic and Diluted   31,750,106    31,750,106 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2

 

 

PowerVerde, Inc and Subsidiary

Condensed Consolidated Changes in Stockholders’ Equity (Deficit)

For the three months ended March 31, 2019 and 2018 

(Unaudited)

 

For the three months ended March 31, 2018               
   Preferred stock  Common stock  Additional
paid-in
capital
  Accumulated deficit  Treasury stock  Total
Balances at December 31, 2017  $    3,981    12,129,331    (11,378,720)   (491,139)   263,453 
Net income                  56,624         56,624 
Balances at March 31, 2018        3,981    12,129,331    (11,322,096)   (491,139)   320,077 

 

For the three months ended March 31, 2019               
   Preferred stock  Common stock  Additional
paid-in
capital
  Accumulated deficit  Treasury stock  Total
Balances at December 31, 2018  $    3,981    12,609,980    (12,057,798)   (491,139)   65,024 
Net loss                  (95,151)        (95,151)
Balances at March 31, 2019        3,981    12,609,980    (12,152,949)   (491,139)   (30,127)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3

 

 

PowerVerde, Inc. and Subsidiary
Condensed Consolidated Statements of Cash Flows
For the three months ended March 31, 2019 and 2018
(Unaudited
)

 

   2019  2018
Cash Flows from Operating Activities          
Net (Loss) income  $(95,151)  $56,624 
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:          
Depreciation and amortization   4,054    8,440 
Changes in operating assets and liabilities:          
Accounts receivable, prepaid expenses and other assets   292    200,400 
Accounts payable and accrued expenses   33,665    (81,315)
           
Cash (Used) Provided by Operating Activities   (57,140)   184,149 
           
Cash Flows from Financing Activities          
Proceeds from notes payable, related party   290,000     
Payments for debt issuance costs   (22,279)    
Payment on notes payable, related party       (150,000)
           
Cash Provided by (used in) Financing Activities   267,721    (150,000)
           
Net Change in Cash and Cash Equivalents   209,661    34,149 
           
Cash and Cash Equivalents at Beginning of Period   8,482    1,336 
           
Cash and Cash Equivalents at End of Period  $218,143   $35,485 
           
Supplemental Disclosure of Cash Flow Information          
Cash paid during the period for interest  $   $698 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

 

PowerVerde, Inc. and Subsidiary

 

Notes to Unaudited Condensed Consolidated Financial Statements

 

March 31, 2019

 

Note 1 – Condensed Consolidated Financial Statements

 

The accompanying unaudited condensed consolidated financial statements prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report of PowerVerde, Inc. (“PowerVerde,” “we,” “us,” “our,” or the “Company”) as of and for the year ended December 31, 2018. The results of operations for the three months ended March 31, 2019, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of PowerVerde, Inc., formerly known as Vyrex Corporation (the “Company”), and PowerVerde Systems, Inc., formerly known as PowerVerde, Inc., its wholly-owned subsidiary. Intercompany balances and transactions have been eliminated in consolidation.

 

Note 2 – Going Concern

 

We have financed our operations since inception through the sale of debt and equity securities and through Biotech IP licensing revenues which expired in March 2018. As of March 31, 2019, we had working capital of $165,916 compared to working capital deficit of $9,788 at December 31, 2018. This improvement in working capital is due primarily to the sale of related party notes payable during this period.

 

The Company has historically relied upon unrelated and related party debt and equity financing to fund its cash flow shortages and will require either additional debt or equity financing to sustain its operations. The Company’s revenues through 2018 were derived mainly from royalties under its biotech licensing agreement, which expired in March 2018. Those factors create substantial doubt about the Company’s ability to continue as a going concern.

 

The Company continues to seek funding from private debt and equity investors, as it needs to promptly raise substantial additional capital in order to finance its plan of operations. There can be no assurance that the Company will be able to promptly raise the necessary additional funds on commercially acceptable terms, if at all. If the Company does not raise the necessary funds, it may be forced to cease operations.

 

Note 3 – Summary of Significant Accounting Policies

 

Nature of Business

 

The Company is devoting substantially all of its present efforts to establish a new business involving the development and commercialization of clean energy electric power generation systems, and none of its planned principal operations have commenced. However, royalties from licenses unrelated to planned principal operations were recognized as revenue through March 2018, when the underlying license agreement terminated. No material revenues from this planned principal operation have been generated.

 

Cash Equivalents

 

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.

 

5

 

 

Accounts Receivable

 

Accounts receivable consist of balances due from assembly services. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2019, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.

 

Revenue Recognition

 

Royalties are recognized as earned in the period the sales to which the royalties relate occur. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer. Revenues recognized under these agreements amount to 100% of total revenues for the three months ended March 31, 2019 and 2018.

 

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.

 

Impairment of Long-Lived Assets

 

Impairment losses are recorded on long-lived assets (property, equipment and intellectual property) used in operations when impairment indicators are present and the undiscounted expected cash flows estimated to be generated by those assets are less than the carrying value of such assets. No impairment losses have been recognized during the three months ended March 31, 2019 or 2018.

 

Stock-based Compensation

 

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

 

Common Stock Purchase Warrants

 

The Company accounts for common stock purchase warrants in accordance with ASC Topic 815- 40, “Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASC 815-40”). Based on the provisions of ASC 815- 40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company, or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of December 31, 2018 and March 31, 2019 were classified as equity.

 

6

 

 

Accounting for Uncertainty in Income Taxes

 

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements, and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

 

Research and Development Costs

 

The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $35,059 and $35,292 for the three months ended March 31, 2019 and 2018, respectively.

 

Earnings (Loss) Per Share

 

Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. Warrants exercisable for 3,675,000 shares and options for 5,750,500 shares were excluded from weighted average common shares outstanding on a diluted basis.

 

Financial instruments

 

The Company carries cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and notes payable, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature or market interest rates on interest bearing debt.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

 

Note 4 – Recent Accounting Pronouncements

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”). Topic 606 supersedes the revenue recognition requirements in ASU Topic 605, Revenue Recognition (“Topic 605”), and requires the recognition of revenue when promised goods or services are transferred to customers in an amount that reflects the considerations to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 also includes Subtopic 340-40, Other Assets and Deferred Costs- Contracts with Customers, which discussed the deferral of incremental costs of obtaining a contract with a customer, including the period of amortization of such costs. The new standard was adopted by the Company in our fiscal year beginning January 1, 2018. The impact of adoption of the new standard on our revenue recognition was not significant; accordingly, there was no cumulative effect adjustment of adoption on January 1, 2018 retained earnings.

 

7

 

 

Note 4 – Recent Account Pronouncements (continued)

 

We have reviewed each of our current contracts for the related performance obligations and related revenue and expense recognition implications. A performance obligation under the new revenue standard is defined as a promise to provide a “distinct” good or service to a customer. The Company has determined that the assembly services is a performance obligation for which a transaction price has been established in the manufacturing agreement. The assembly of each unit stands on its own. Revenue related to assembly services is recognized as revenue when the assembled product is delivered to the customer. The Company has also determined that the performance obligation associated with our royalty revenues was the ongoing delivery of the license to which the royalties relate. Royalty revenues were recognized based on the contract royalty rate applied to licensee sales in the periods during which such sales occurred.

 

In February 2016, the FASB issued ASU 2016-02, “Leases,” which created a new Topic, ASC Topic 842 and established the core principle that a lessee should recognize the assets, representing rights-of-use, and liabilities to make lease payments that arise from leases. For leases with a term of 12 months or less, a lessee is permitted to make an election under which such assets and liabilities would not be recognized, and lease expense would be recognized generally on a straight-line basis over the lease term. This ASU is effective for public entities for interim and annual reporting periods beginning after December 15, 2018. The Company adopted ASU Topic 842 on January 1, 2019 and such adoption did not have any impact on the Company’s financial statements.

 

In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718).” ASU 2018-07 simplifies the accounting for nonemployee stock-based payment transactions. This ASU is effective for public entities for interim and annual reporting periods beginning after December 15, 2018, and early application is permitted. The adoption of this guidance on January 1, 2019 did not have an impact on the Company’s financial statements.

 

Note 5 – Intellectual Property and License Agreement

 

On June 30, 2015, the Company entered into an Assignment Agreement with VyrexIP Holdings Inc., a company owned by Company shareholder Edward Gomez, for the purchase of intellectual property. The net price of these assets was comprised of a down payment of $16,116 and a $58,436 promissory note to the seller due July 15, 2016, partially offset by assignment by the seller to the Company of a $38,000 promissory note due November 14, 2015, issued by the seller’s licensee Epalex Corporation, a company of which Mr. Gomez is chairman and a major stockholder. This note was paid in full in November 2015.

 

On June 1, 2016, the Company entered into a ten-year License Agreement with Helidyne LLC for total consideration of $100,000 to utilize the Helidyne intellectual property in the manufacturing of planetary rotor expanders and the incorporation of same in the Company’s distributed electric power generation systems. The license agreement also grants the Company an exclusive license to sell the expanders whether manufactured by Helidyne or by the Company. The Company’s royalty obligation begins on the earlier of the commercialization of the product or three years from the effective date of the agreement. Once the royalty obligation begins, the minimum annual royalty is $50,000 for each of the first six years, and $100,000, per commercial year, for the remainder of the agreement.

 

For the three months ended March 31, 2019 and 2018, amortization expense was $2,500 and $4,874 respectively, and accumulated amortization of the intangible assets was $28,322 and $25,822 at March 31, 2019 and December 31, 2018, respectively.

 

Future amortization of the intangible assets is as follows as of March 31, 2019:

 

Year ending December 31:    
2019  $7,500 
2020   10,000 
2021   10,000 
Thereafter   44,178 
Total  $71,678 

 

8

 

 

Note 6 – Stockholders’ Equity (Deficit)

 

Warrants

 

A summary of warrants issued, exercised and expired during the three months ended March 31, 2019 is as follows:

 

    Shares  Weighted Average Exercise Price  Aggregate Intrinsic Value
Balance at December 31, 2018   975,000   $.11   $ 
Issued            
Expired            
Balance at March 31, 2019   975,000   $.11   $ 

 

Note 7 – Stock Options

 

Stock option activity for the quarter ended March 31, 2019, is summarized as follows:

 

    Shares  Weighted Average Exercise Price  Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2018   11,180,500   $0.20    7.02 
Granted            
Expired/forfeited            
Options outstanding at March 31, 2019   11,180,500   $0.20    6.27 

 

Total stock option compensation for the three months ended March 31, 2019 and 2018 was $0. There is no unrecognized compensation expense associated with the options.

 

Note 8 – Notes Payable to Related Parties

 

In the first quarter of 2019, the Company issued Series B Convertible Promissory Notes totaling $290,000 to stockholders. The notes are to be paid in one principal payment, along with any unpaid interest, by December 31, 2021. Interest is payable semiannually at 10%. The notes are convertible into common stock at a price of $.20 per share through December 31, 2019, $.30 per share from January 1, 2020 through December 31, 2020, and $.40 per share from January 1, 2021 through the maturity date of December 31, 2021.

 

Note 9 - Commitments and Contingencies

 

On June 25, 2015, Company consultant Hank Leibowitz assigned to the Company a patent he obtained for a system and method for using high temperature sources in Rankine cycle power systems. The Company has agreed to pay Mr. Leibowitz a 2% royalty for any and all revenues of products and/or project sales by the Company based on the subject patent.

 

9

 

 

On June 1, 2016, the Company entered into a ten-year License Agreement with Helidyne LLC to utilize the Helidyne intellectual property in order to use Helidyne expanders in Powerverde systems and to sell Helidyne expanders. As part of the licensing agreement the Company committed to purchase two 50 kW expanders, at a price of $25,000 each, on or before the sixth month anniversary of the agreement. The $50,000 was payable in two monthly installments of $25,000 beginning October 2016. The Company had made payments totaling $38,750, towards the purchase of the expanders. Due to Helidyne’s failure to perform under the agreement, the Company has not made any further payments to Helidyne and does not intend to do so unless and until Helidyne performs as required. Helidyne has not objected to the Company’s position, and it is very unlikely that Helidyne will ever be able to perform.

 

The Company agreed to pay Helidyne LLC a royalty of 3% of sales, subject to a minimum annual royalty of $50,000 beginning on the earlier of commercialization of the product or three years from the effective date of the agreement. This minimum royalty would be payable only if Helidyne performs as required, which is very unlikely, or if the Company elects to produce its own expanders using Helidyne technology. The Company does intend to produce these expanders directly or through a contract manufacturer in the future. See Note 5.

 

On April 15, 2017, the Company entered into an assembly agreement with Liberty Plugins, Inc. (“Liberty”) to assemble Liberty’s Hydra electronic vehicle charging systems and ship completed Hydras to Liberty’s facility in Santa Barbara, California (the “Liberty Agreement”). Liberty has agreed to pay $1,000 for the first 10 Hydras assembled in a month, $750 per Hydra for the next 10 Hydras assembled per month and $500 per Hydra for each Hydra assembled above 20 per month. The Company has never assembled/shipped more than 10 Hydras in any month and does not expect to do so in the future. As of March 31, 2019, the Company has built and shipped 70 Hydras. Revenue of $5,000 and $3,000 for these products is reflected in the net revenue on the Company’s condensed consolidated statements of operations for the three months ended March 31, 2019 and 2018, respectively.

 

Note 10 - Related Party Transactions

 

Since July 2010, the accounting firm J.L. Hofmann & Associates, P.A. (“JLHPA”), whose principal is our CFO John L. Hofmann, has provided financial consulting and accounting services to the Company. In December 2017, J.L. Hofmann & Associates, P.A. merged with Kabat, Schertzer, De La Torre, Taraboulos & Co, LLC (“KSDT”). The Company paid $9,614 and $10,730 for its services in the three months ended March 31, 2019 and 2018, respectively.

 

Note 11 – Subsequent Events

 

The Company’s management evaluated subsequent events through May 14, 2019, in connection with the preparation of these condensed consolidated financial statements, which is the date these financial statements were available to be issued. There are no subsequent events to report as of this date, except that in May 2019 the Company issued a Series B Convertible Promissory Note in the principal amount of $10,000 to a stockholder in connection with a loan in the same amount. Consequently, Series B Convertible Promissory Notes have been issued in an aggregate principal amount of $300,000 during the first two quarters of 2019. See Note 8.

 

10

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward Looking Statements

 

Readers are cautioned that the statements in this Report that are not descriptions of historical facts may be forward-looking statements that are subject to risks and uncertainties. This Report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are based on the beliefs of our management, as well as on assumptions made by and information currently available to us as of the date of this Report. When used in this Report, the words “plan,” “will,” “may,” “anticipate,” “believe,” “estimate,” “expect,” “intend,” “project” and similar expressions are intended to identify such forward-looking statements. Although we believe these statements are reasonable, actual actions, operations and results could differ materially from those indicated by such forward-looking statements as a result of the risk factors included in our 2018 Annual Report, or other factors. We must caution, however, that this list of factors may not be exhaustive and that these or other factors, many of which are outside of our control, could have a material adverse effect on us and our ability to achieve our objectives. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above.

 

The following discussion and analysis should be read in conjunction with the financial statements and notes thereto appearing elsewhere herein.

 

Critical Accounting Policies

 

The condensed consolidated financial statements of PowerVerde, Inc. are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of these condensed consolidated financial statements requires our management to make estimates and assumptions about future events that effect the amounts reported in the financial statements and related notes. Future events and their effects cannot be determined with absolute certainty. Therefore, the determination of estimates requires the exercise of judgment. We believe the following critical accounting policies affect its more significant judgments and estimates used in the preparation of financial statements.

 

Accounting for Uncertainty in Income Taxes

 

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements, and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

 

Based on our evaluation, we have concluded that there are no significant uncertain tax positions requiring recognition in our condensed consolidated financial statements. Our evaluation was performed for the tax years ended December 31, 2013, 2014, 2015, 2016, and 2017, the tax years which remain subject to examination by major tax jurisdictions as of March 31, 2019.

 

We may from time to time be assessed interest or penalties by major tax jurisdictions, although any such assessments historically have been minimal and immaterial to our financial results. In the event we have received an assessment for interest and/or penalties, it has been classified in the condensed consolidated financial statements as general and administrative expense.

 

11

 

 

Revenue Recognition

 

Revenue from royalties and assembly services unrelated to the Company’s planned operations is recognized when the goods or services are transferred to the customer. Royalties are recognized as earned in the period the sales to which the royalties relate occur. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer. Revenues recognized under these agreements amount to 100% of total revenues for the three months ended March 31, 2019 and 2018.

 

Common Stock Purchase Warrants

 

The Company accounts for common stock purchase warrants in accordance with ASC Topic 815- 40, Derivatives and Hedging – Contracts in Entity’s Own Equity (“ASC 815-40”). Based on the provisions of ASC 815- 40, the Company classifies as equity any contracts that (i) require physical settlement or netshare settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of March 31, 2019 and 2018 were classified as equity.

 

Intellectual Property

 

The Company reviews intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. In the event of impairment, the Company would discount the future cash flows using its then estimated incremental borrowing rate to estimate the amount of the impairment.

 

Stock-based compensation.

 

We account for stock-based compensation based on ASC Topic 718-Stock Compensation which requires expensing of stock options and other share-based payments based on the fair value of each stock option awarded. The fair value of each stock option is estimated on the date of grant using the Black-Scholes valuation model. This model requires management to estimate the expected volatility, expected dividends, and expected term as inputs to the valuation model.

 

Overview

 

From January 1991 until October 2005, the Company devoted substantially all of its efforts and resources to research and development related to its unsuccessful Biotech Business, in particular the study of biological oxidation and antioxidation directed to the development of potential therapeutic products for the treatment of various diseases and conditions. In the most recent years, the Company’s research focused mainly on targeted antioxidant therapeutics and nutraceuticals. The Company, has generated only limited revenue from product sales and has relied primarily on equity financing, licensing revenues, and various debt instruments for its working capital. The Company has been unprofitable since its inception.

 

Following the cessation of material Biotech Business operations in October 2005, the Company turned its primary focus to seeking an appropriate merger partner for its public shell. This resulted in the February 2008 Merger with Vyrex. In March 2009, we assigned most of our Biotech intellectual property other than our rights under existing licensing agreements (the “Biotech IP”) to an investor in exchange for his agreement to pay all future expenses relating to the Biotech IP and to pay us 20% of any net proceeds received from future sale and/or licensing of the Biotech IP. We do not expect this arrangement to generate material revenues.

 

12

 

 

Since the Merger, we have focused on the development, testing and commercialization of our electric power systems, in particular, their applicability to thermal and natural gas pipeline operations. Our business is subject to significant risks, including the risks inherent in our research and development efforts, uncertainties associated with obtaining and enforcing patents and intense competition. See “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 29, 2019.

 

Except as specifically noted to the contrary, the following discussion relates only to PowerVerde since, as a result of the Merger, the only historical financial statements presented for the Company in periods following the Merger are those of the operating entity, PowerVerde.

 

Results of Operations

 

Three Months Ended March 31, 2019 as Compared to Three Months Ended March 31, 2018

 

Since inception, we have focused on the development, testing and commercialization of our clean energy electric power generation systems. We had no revenues from sales in the first quarter of 2019 and 2018 – but we recorded $0 and $159,094 in Biotech IP licensing fees (based on pre-Merger contracts), respectively. Also, we generated $5,000 and $3,000 in revenue for assembly revenues under the Liberty Agreement in the first quarter of 2019 and 2018, respectively. In both years, we had substantial expenses due to our ongoing research and development activities and efforts to commercialize our systems, as well as substantial administrative expenses associated with our status as a public company. Our research and development expenses have remained consistent in the first quarter of 2019 as compared to the first quarter of 2018. Our general and administrative expenses decreased by $9,596 in the first quarter of 2019 as compared to 2018, primarily because of decreased amortization and depreciation expense, as well as decreased legal fees. Primarily as a result of the March 2018 expiration of our Biotech IP license agreement, our net loss was $95,151 in the first quarter of 2019 as compared to net income of $56,624 in the first quarter of 2018. Substantial net losses are expected until we are able to successfully commercialize and market our systems, as to which there can be no assurance. Any taxes that might result from net income for financial reporting purposes would be eliminated through use of a portion of the Company’s net operating loss carryforward.

 

Liquidity and Capital Resources

 

We have financed our operations since inception principally through the sale of debt and equity securities. Also, from 2012 through March 2018 we received material amounts of Biotech IP licensing fees. As of March 31, 2019, we had working capital of $165,916 compared to a working capital deficit of $9,788 at December 31, 2018. Our improved working capital position is due primarily to the notes payable issued in the first quarter of 2019.

 

Our Biotech IP license agreement expired in March 2018 due to the expiration of our underlying patents. Consequently, we have no further material source of revenues. We are generating some revenue by using our employee to provide part-time skilled manufacturing services to a third party; however, we expect this arrangement to generate no more than $5,000 per month. We expect to generate substantial revenue from the 374Water/Duke project in 2019 if we receive the expected purchase order; however, there can be no assurance that we will receive the purchase order.

 

We continue to seek funding from private equity and debt investors, as we need to promptly raise substantial additional capital in order to finance our plan of operations and commercialize our systems. There can be no assurance that we will be able to promptly raise the necessary funds. If we do not promptly raise the necessary funds, we may be forced to cease operations.

 

13

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not applicable.

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and President, evaluated the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective.

 

Management’s Annual Report on Internal Control Over Financial Reporting

 

Management of the Company is responsible for establishing and maintaining adequate control over financial reporting. Our internal control system was designed to provide reasonable assurance to our management and Board of Directors regarding the preparation and fair presentation of financial statements.

 

All internal controls over financial reporting, no matter how well designed, have inherent limitations, including the possibility of human error and the circumvention of overriding of controls. Therefore, even effective internal control over financial reporting can provide only reasonable, and not absolute, assurance with respect to financial statement preparation and presentation. Further, because of changes in conditions, the effectiveness of internal controls over financial reporting may vary over time. Because of its inherent limitations, internal controls over financial reporting may also fail to prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.

 

Our Chief Executive Officer and Chief Financial Officer assessed the effectiveness of our internal control over financial reporting as of December 31, 2018. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control—An Integrated Framework. Based on this evaluation, our management concluded that, as of March 31, 2019, our internal control over financial reporting was effective.

 

No Attestation Report

 

This quarterly report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this quarterly report.

 

Changes in Internal Control Over Financial Reporting

 

There were no significant changes in internal control over financial reporting during the first quarter of 2019 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

14

 

 

PART II OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

None.

 

Item 1A. Risk Factors.

 

There are no material changes to the risk factors set forth in Part I, Item 1A, “Risk Factors,” of the 2018 Annual Report. Please refer to that section for disclosure regarding the risks and uncertainties related to our business.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

In the first quarter of 2019, we issued Series B Convertible Promissory Notes totaling $290,000 to stockholders in connection with a loan in the same amount. The notes are to be paid in one principal payment, along with any unpaid interest, by December 31, 2021. Interest is payable semiannually at 10%. The notes are convertible into common stock at a price of $.20 per share through December 31, 2019, $.30 per share from January 1, 2020 through December 31, 2020, and $.40 per share from January 1, 2021 through the maturity date of December 31, 2021.

 

In the second quarter of 2019, the Company issued a Series B Convertible Promissory Note in the principal amount of $10,000 to a stockholder in connection with a loan in the same amount.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

Not applicable.

 

15

 

 

Item 6. Exhibits.

 

(a)Exhibits
  
31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1 Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2 Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101.INS XBRL INSTANCE DOCUMENT
   
101.SCH XBRL TAXONOMY EXTENSION SCHEMA
   
101.CAL XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
   
101.DEF XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
   
101.LAB XBRL TAXONOMY EXTENSION LABEL LINKBASE
   
101.PRE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

 


 

16

 

 

SIGNATURES

 

In accordance with Section 13(a) or 15(d) of the Exchange Act, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  POWERVERDE, INC.
     
     
Dated: May 14, 2019 By: /s/ Richard H. Davis
    Richard H. Davis
    Chief Executive Officer
     
Dated: May 14, 2019 By: /s/ John L. Hofmann
    John L. Hofmann
    Chief Financial Officer

 

17

 

 

Exhibit Index

 

Exhibit
No.
  Description    
31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002  
     
101.INS   XBRL INSTANCE DOCUMENT
     
101.SCH   XBRL TAXONOMY EXTENSION SCHEMA
     
101.CAL   XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
     
101.DEF   XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
     
101.LAB   XBRL TAXONOMY EXTENSION LABEL LINKBASE
     
101.PRE   XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE    

 

18 

 

 

EX-31.1 2 ex31_1.htm EXHIBIT 31.1

 

  

Exhibit 31.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Richard H. Davis, certify that:

 

1.I have reviewed this Form 10-Q of PowerVerde, Inc.

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated:  May 14, 2019 /s/ Richard H. Davis    
    Richard H. Davis, Chief Executive Officer

 

 

 

 

EX-31.2 3 ex31_2.htm EXHIBIT 31.2

 

  

 Exhibit 31.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, John L. Hofmann, certify that:

 

1.I have reviewed this Form 10-Q of PowerVerde, Inc.

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated:  May 14, 2019 /s/ John L. Hofmann    
    John L. Hofmann, Chief Financial Officer

 

 

 

 

EX-32.1 4 ex32_1.htm EXHIBIT 32.1

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED  

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Richard H. Davis, certify as follows:

 

1.To the best of my knowledge, the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, fully complies in all material respects with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and

 

2.To the best of my knowledge, based upon a review of the report, the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

By: /s/ Richard H. Davis      
  Richard H. Davis  
  Chief Executive Officer
May 14, 2019
 

 

 

 

EX-32.2 5 ex32_2.htm EXHIBIT 32.2

 

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, John L. Hofmann, certify as follows:

 

1.To the best of my knowledge, the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, fully complies in all material respects with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and

 

2.To the best of my knowledge, based upon a review of the report, the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

By: /s/ John L. Hofmann      
  John L. Hofmann  
  Chief Financial Officer
May 14, 2019
 

 

 

 

 

EX-101.INS 6 pwvi-20190331.xml XBRL INSTANCE FILE 0000933972 2018-12-31 0000933972 2019-01-01 2019-03-31 0000933972 2019-03-31 0000933972 2018-01-01 2018-03-31 0000933972 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-03-31 0000933972 us-gaap:EmployeeStockOptionMember 2018-12-31 0000933972 2015-06-30 0000933972 2015-06-01 2015-06-30 0000933972 2019-05-14 0000933972 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000933972 us-gaap:RetainedEarningsMember 2017-12-31 0000933972 us-gaap:WarrantMember 2019-01-01 2019-03-31 0000933972 us-gaap:OptionMember 2019-01-01 2019-03-31 0000933972 pwvi:HelidyneLLCMember 2016-05-31 2016-06-02 0000933972 pwvi:HelidyneLLCMember 2016-06-01 0000933972 2015-06-25 0000933972 2016-10-01 0000933972 us-gaap:CommonStockMember 2017-12-31 0000933972 us-gaap:CommonStockMember 2018-12-31 0000933972 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000933972 us-gaap:TreasuryStockMember 2017-12-31 0000933972 us-gaap:TreasuryStockMember 2018-12-31 0000933972 us-gaap:RetainedEarningsMember 2018-12-31 0000933972 us-gaap:PreferredStockMember 2018-12-31 0000933972 us-gaap:PreferredStockMember 2017-12-31 0000933972 us-gaap:CommonStockMember 2019-03-31 0000933972 us-gaap:CommonStockMember 2018-03-31 0000933972 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000933972 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0000933972 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000933972 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0000933972 us-gaap:RetainedEarningsMember 2019-03-31 0000933972 us-gaap:RetainedEarningsMember 2018-03-31 0000933972 us-gaap:TreasuryStockMember 2019-03-31 0000933972 us-gaap:TreasuryStockMember 2018-03-31 0000933972 2017-12-31 0000933972 2018-03-31 0000933972 us-gaap:SubsequentEventMember 2019-05-01 2019-05-14 0000933972 us-gaap:EmployeeStockOptionMember 2019-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 71678 44178 10000 10000 7500 9614 10730 0.03 0.02 50000 0.10 0 0.11 0.11 25822 28322 16116 38000 58436 2015-11-14 2016-07-15 10-Q 2019-03-31 false 0000933972 --12-31 Yes 2019 Q1 POWERVERDE, INC. 25822 28322 50000000 50000000 0 0 0 0 0.0001 0.0001 200000000 200000000 40300106 40300106 31750106 31750106 8550000 8550000 2500 4874 975000 975000 31750106 65024 -30127 12129331 -11378720 3981 3981 12609980 -491139 -491139 -12057798 3981 3981 12609980 12129331 -12152949 -11322096 -491139 -491139 263453 320077 -95151 56624 -95151 56624 Non-accelerated Filer false true 1.00 1.00 0 0 3675000 5750500 100000 11180500 11180500 0.2 0.2 P7Y7D P6Y3M8D 290000 2021-12-31 38750 50000 25000 25000 5000 3000 Company issued a Series B Convertible Promissory Note in the principal amount of $10,000 to a stockholder in connection with a loan in the same amount. Consequently, Series B Convertible Promissory Notes have been issued in an aggregate principal amount of $300,000 during the first two quarters of 2019. 107007 107641 39136 340522 39136 72801 39136 72801 104160 310395 74178 71678 74178 71678 634 0 29348 238717 10000 5000 8482 218143 0 0 3981 3981 12609980 12609980 491139 491139 -12057798 -12152949 104160 310395 31750106 31750106 0 0 0 0 -95151 56624 -4294 216 4294 698 0 914 -90857 56408 95857 105686 60798 70394 35059 35292 5000 162094 0 698 218143 35485 8482 1336 209661 34149 267721 -150000 -57140 184149 33665 -81315 -292 -200400 4054 8440 <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1 &#8211; Condensed Consolidated Financial Statements</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report of PowerVerde, Inc. (&#8220;PowerVerde,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or the &#8220;Company&#8221;) as of and for the year ended December 31, 2018. The results of operations for the three months ended March 31, 2019, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of PowerVerde, Inc., formerly known as Vyrex Corporation (the &#8220;Company&#8221;), and PowerVerde Systems, Inc., formerly known as PowerVerde, Inc., its wholly-owned subsidiary. Intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Note 10 - Related Party Transactions</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since July 2010, the accounting firm J.L. Hofmann &#38; Associates, P.A. (&#8220;JLHPA&#8221;), whose principal is our CFO John L. Hofmann, has provided financial consulting and accounting services to the Company. In December 2017, J.L. Hofmann &#38; Associates, P.A. merged with Kabat, Schertzer, De La Torre, Taraboulos &#38; Co, LLC (&#8220;KSDT&#8221;). The Company paid $9,614 and $10,730 for its services in the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Note 11 &#8211; Subsequent Events</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s management evaluated subsequent events through May 10, 2019, in connection with the preparation of these condensed consolidated financial statements, which is the date these financial statements were available to be issued. There are no subsequent events to report as of this date, except that in May 2019 the Company issued a Series B Convertible Promissory Note in the principal amount of $10,000 to a stockholder in connection with a loan in the same amount. Consequently, Series B Convertible Promissory Notes have been issued in an aggregate principal amount of $300,000 during the first two quarters of 2019. See Note 8.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><u>Nature of Business </u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is devoting substantially all of its present efforts to establish a new business involving the development and commercialization of clean energy electric power generation systems, and none of its planned principal operations have commenced. However, royalties from licenses unrelated to planned principal operations were recognized as revenue through March 2018, when the underlying license agreement terminated. No material revenues from this planned principal operation have been generated.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><u>Cash Equivalents</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><u>Accounts Receivable</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable consist of balances due from assembly services. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2019, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><u>Property and Equipment</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><u>Impairment of Long-Lived Assets</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Impairment losses are recorded on long-lived assets (property, equipment and intellectual property) used in operations when impairment indicators are present and the undiscounted expected cash flows estimated to be generated by those assets are less than the carrying value of such assets. No impairment losses have been recognized during the three months ended March 31, 2019 or 2018.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><u>Stock-based Compensation</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 &#8211; &#8220;Stock Compensation&#8221; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><u>Common Stock Purchase Warrants</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for common stock purchase warrants in accordance with ASC Topic 815- 40, &#8220;Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity&#8221; (&#8220;ASC 815-40&#8221;). Based on the provisions of ASC 815- 40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company, or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of December 31, 2018 and March 31, 2019 were classified as equity.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><u>Accounting for Uncertainty in Income Taxes</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#160;follows the provisions of ASC Topic 740-10, &#8220;Accounting for Uncertainty in Income Taxes&#8221; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements, and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><u>Research and Development Costs</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $35,059 and $35,292 for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><u>Earnings (Loss) Per Share</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#8220;Earnings per Share&#8221;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. Warrants exercisable for 3,675,000 shares and options for 5,750,500 shares were excluded from weighted average common shares outstanding on a diluted basis.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><u>Use of Estimates</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Future amortization of the intangible assets is as follows as of March 31, 2019:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt"><b>Year ending December 31:</b></font></td> <td>&#160;</td> <td colspan="3" style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%; padding-left: 10pt"><font style="font-size: 8pt">2019</font></td> <td style="width: 10%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 25%; text-align: right"><font style="font-size: 8pt">7,500</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 8pt">2020</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">10,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 8pt">2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">10,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 8pt">Thereafter</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">44,178</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 8pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">71,678</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> 0 0 10866 15574 0 267721 0 267721 290000 0 The notes are convertible into common stock at a price of $.20 per share through December 31, 2019, $.30 per share from January 1, 2020 through December 31, 2020, and $.40 per share from January 1, 2021 through the maturity date of December 31, 2021. 0 150000 -9788 165916 22279 0 <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 &#8211; Going Concern</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have financed our operations since inception through the sale of debt and equity securities and through Biotech IP licensing revenues which expired in March 2018. As of March 31, 2019, we had working capital of $165,916 compared to working capital deficit of $9,788 at December 31, 2018. This improvement in working capital is due primarily to the sale of related party notes payable during this period.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has historically relied upon unrelated and related party debt and equity financing to fund its cash flow shortages and will require either additional debt or equity financing to sustain its operations. The Company&#8217;s revenues through 2018 were derived mainly from royalties under its biotech licensing agreement, which expired in March 2018. Those factors create substantial doubt about the Company&#8217;s ability to continue as a going concern.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company continues to seek funding from private debt and equity investors, as it needs to promptly raise substantial additional capital in order to finance its plan of operations. There can be no assurance that the Company will be able to promptly raise the necessary additional funds on commercially acceptable terms, if at all. If the Company does not raise the necessary funds, it may be forced to cease operations.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3 &#8211; Summary of Significant Accounting Policies</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Nature of Business </u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is devoting substantially all of its present efforts to establish a new business involving the development and commercialization of clean energy electric power generation systems, and none of its planned principal operations have commenced. However, royalties from licenses unrelated to planned principal operations were recognized as revenue through March 2018, when the underlying license agreement terminated. No material revenues from this planned principal operation have been generated.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash Equivalents</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts Receivable</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable consist of balances due from assembly services. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2019, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Royalties are recognized as earned in the period the sales to which the royalties relate occur. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer. Revenues recognized under these agreements amount to 100% of total revenues for the three months ended March 31, 2019 and 2018.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Property and Equipment</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Impairment of Long-Lived Assets</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Impairment losses are recorded on long-lived assets (property, equipment and intellectual property) used in operations when impairment indicators are present and the undiscounted expected cash flows estimated to be generated by those assets are less than the carrying value of such assets. No impairment losses have been recognized during the three months ended March 31, 2019 or 2018.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock-based Compensation</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 &#8211; &#8220;Stock Compensation&#8221; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Common Stock Purchase Warrants</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for common stock purchase warrants in accordance with ASC Topic 815- 40, &#8220;Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity&#8221; (&#8220;ASC 815-40&#8221;). Based on the provisions of ASC 815- 40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company, or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of December 31, 2018 and March 31, 2019 were classified as equity.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounting for Uncertainty in Income Taxes</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#160;follows the provisions of ASC Topic 740-10, &#8220;Accounting for Uncertainty in Income Taxes&#8221; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements, and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Research and Development Costs</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $35,059 and $35,292 for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Earnings (Loss) Per Share</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#8220;Earnings per Share&#8221;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. Warrants exercisable for 3,675,000 shares and options for 5,750,500 shares were excluded from weighted average common shares outstanding on a diluted basis.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Financial instruments</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company carries cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and notes payable, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature or market interest rates on interest bearing debt.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4 &#8211; Recent Accounting Pronouncements</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-09, Revenue from Contracts with Customers (&#8220;Topic 606&#8221;). Topic 606 supersedes the revenue recognition requirements in ASU Topic 605, Revenue Recognition (&#8220;Topic 605&#8221;), and requires the recognition of revenue when promised goods or services are transferred to customers in an amount that reflects the considerations to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 also includes Subtopic 340-40, <i>Other Assets and Deferred Costs- Contracts with Customers</i>, which discussed the deferral of incremental costs of obtaining a contract with a customer, including the period of amortization of such costs. The new standard was adopted by the Company in our fiscal year beginning January 1, 2018. The impact of adoption of the new standard on our revenue recognition was not significant; accordingly, there was no cumulative effect adjustment of adoption on January 1, 2018 retained earnings.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have reviewed each of our current contracts for the related performance obligations and related revenue and expense recognition implications. A performance obligation under the new revenue standard is defined as a promise to provide a &#8220;distinct&#8221; good or service to a customer. The Company has determined that the assembly services is a performance obligation for which a transaction price has been established in the manufacturing agreement. The assembly of each unit stands on its own. Revenue related to assembly services is recognized as revenue when the assembled product is delivered to the customer. The Company has also determined that the performance obligation associated with our royalty revenues was the ongoing delivery of the license to which the royalties relate. Royalty revenues were recognized based on the contract royalty rate applied to licensee sales in the periods during which such sales occurred.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02, <i>&#8220;Leases,&#8221; </i>which created a new Topic, ASC Topic 842 and established the core principle that a lessee should recognize the assets, representing rights-of-use, and liabilities to make lease payments that arise from leases. For leases with a term of 12 months or less, a lessee is permitted to make an election under which such assets and liabilities would not be recognized, and lease expense would be recognized generally on a straight-line basis over the lease term. This ASU is effective for public entities for interim and annual reporting periods beginning after December 15, 2018. The Company adopted ASU Topic 842 on January 1, 2019 and such adoption did not have any impact on the Company&#8217;s financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2018, the FASB issued ASU 2018-07, <i>&#8220;Compensation &#8211; Stock Compensation (Topic 718).&#8221; </i>ASU 2018-07 simplifies the accounting for nonemployee stock-based payment transactions. This ASU is effective for public entities for interim and annual reporting periods beginning after December 15, 2018, and early application is permitted. The adoption of this guidance on January 1, 2019 did not have an impact on the Company&#8217;s financial statements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Note 5 &#8211; Intellectual Property and License Agreement</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 30, 2015, the Company entered into an Assignment Agreement with VyrexIP Holdings Inc., a company owned by Company shareholder Edward Gomez, for the purchase of intellectual property. The net price of these assets was comprised of a down payment of $16,116 and a $58,436 promissory note to the seller due July 15, 2016, partially offset by assignment by the seller to the Company of a $38,000 promissory note due November 14, 2015, issued by the seller&#8217;s licensee Epalex Corporation, a company of which Mr. Gomez is chairman and a major stockholder. This note was paid in full in November 2015. Accumulated amortization with respect to this intellectual property was $74,178 and $71,678 at March 31, 2019 and December 31, 2018, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 1, 2016, the Company entered into a ten-year License Agreement with Helidyne LLC for total consideration of $100,000 to utilize the Helidyne intellectual property in the manufacturing of planetary rotor expanders and the incorporation of same in the Company&#8217;s distributed electric power generation systems. The license agreement also grants the Company an exclusive license to sell the expanders whether manufactured by Helidyne or by the Company. The Company&#8217;s royalty obligation begins on the earlier of the commercialization of the product or three years from the effective date of the agreement. Once the royalty obligation begins, the minimum annual royalty is $50,000 for each of the first six years, and $100,000, per commercial year, for the remainder of the agreement.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended March 31, 2019 and 2018, amortization expense was $2,500 and $4,874 respectively, and accumulated amortization of the intangible assets was $28,322 and $25,822 at March 31, 2019 and December 31, 2018, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Future amortization of the intangible assets is as follows as of March 31, 2019:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt"><b>Year ending December 31:</b></font></td> <td>&#160;</td> <td colspan="3" style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%; padding-left: 10pt"><font style="font-size: 8pt">2019</font></td> <td style="width: 10%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 25%; text-align: right"><font style="font-size: 8pt">7,500</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 8pt">2020</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">10,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 8pt">2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">10,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 8pt">Thereafter</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">44,178</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 8pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">71,678</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Note 7 &#8211; Stock Options</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock option activity for the quarter ended March 31, 2019, is summarized as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Shares</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Weighted Average Exercise Price</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Weighted Average Remaining Contractual Life (Years)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 46%"><font style="font-size: 8pt"><b>Options outstanding at December 31, 2018</b></font></td> <td style="width: 5%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid">&#160;</td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">11,180,500</font></td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 5%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid"><font style="font-size: 8pt">$</font></td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">0.20</font></td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 5%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid">&#160;</td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">7.02</font></td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">Granted</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 8pt">Expired/forfeited</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt"><b>Options outstanding at March 31, 2019</b></font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">11,180,500</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">0.20</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">6.27</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Total stock option compensation for the three months ended March 31, 2019 and 2018 was $0. There is no unrecognized compensation expense associated with the options.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 8 &#8211; Notes Payable to Related Parties</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the first quarter of 2019, the Company issued Series B Convertible Promissory Notes totaling $290,000 to stockholders. The notes are to be paid in one principal payment, along with any unpaid interest, by December 31, 2021. Interest is payable semiannually at 10%. The notes are convertible into common stock at a price of $.20 per share through December 31, 2019, $.30 per share from January 1, 2020 through December 31, 2020, and $.40 per share from January 1, 2021 through the maturity date of December 31, 2021.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 9 - Commitments and Contingencies</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2015, Company consultant Hank Leibowitz assigned to the Company a patent he obtained for a system and method for using high temperature sources in Rankine cycle power systems. The Company has agreed to pay Mr. Leibowitz a 2% royalty for any and all revenues of products and/or project sales by the Company based on the subject patent.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 1, 2016, the Company entered into a ten-year License Agreement with Helidyne LLC to utilize the Helidyne intellectual property in order to use Helidyne expanders in Powerverde systems and to sell Helidyne expanders. As part of the licensing agreement the Company committed to purchase two 50 kW expanders, at a price of $25,000 each, on or before the sixth month anniversary of the agreement. The $50,000 was payable in two monthly installments of $25,000 beginning October 2016. The Company had made payments totaling $38,750, towards the purchase of the expanders. Due to Helidyne&#8217;s failure to perform under the agreement, the Company has not made any further payments to Helidyne and does not intend to do so unless and until Helidyne performs as required. Helidyne has not objected to the Company&#8217;s position, and it is very unlikely that Helidyne will ever be able to perform.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company agreed to pay Helidyne LLC a royalty of 3% of sales, subject to a minimum annual royalty of $50,000 beginning on the earlier of commercialization of the product or three years from the effective date of the agreement. This minimum royalty would be payable only if Helidyne performs as required, which is very unlikely, or if the Company elects to produce its own expanders using Helidyne technology. The Company does intend to produce these expanders directly or through a contract manufacturer in the future. See Note 5.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 15, 2017, the Company entered into an assembly agreement with Liberty Plugins, Inc. (&#8220;Liberty&#8221;) to assemble Liberty&#8217;s Hydra electronic vehicle charging systems and ship completed Hydras to Liberty&#8217;s facility in Santa Barbara, California (the &#8220;Liberty Agreement&#8221;). Liberty has agreed to pay $1,000 for the first 10 Hydras assembled in a month, $750 per Hydra for the next 10 Hydras assembled per month and $500 per Hydra for each Hydra assembled above 20 per month. The Company has never assembled/shipped more than 10 Hydras in any month and does not expect to do so in the future. As of March 31, 2019, the Company has built and shipped 70 Hydras. Revenue of $5,000 and $3,000 for these products is reflected in the net revenue on the Company&#8217;s condensed consolidated statements of operations for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Royalties are recognized as earned in the period the sales to which the royalties relate occur. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer. Revenues recognized under these agreements amount to 100% of total revenues for the three months ended March 31, 2019 and 2018.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Financial instruments</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company carries cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and notes payable, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature or market interest rates on interest bearing debt.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock option activity for the quarter ended March 31, 2019, is summarized as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Shares</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Weighted Average Exercise Price</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Weighted Average Remaining Contractual Life (Years)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 46%"><font style="font-size: 8pt"><b>Options outstanding at December 31, 2018</b></font></td> <td style="width: 5%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid">&#160;</td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">11,180,500</font></td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 5%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid"><font style="font-size: 8pt">$</font></td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">0.20</font></td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td> <td style="width: 5%; padding-bottom: 1pt">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid">&#160;</td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">7.02</font></td> <td style="width: 1%; padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">Granted</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 8pt">Expired/forfeited</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt"><b>Options outstanding at March 31, 2019</b></font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">11,180,500</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">0.20</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">6.27</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of warrants issued, exercised and expired during the three months ended March 31, 2019 is as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Shares</b></font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Weighted Average Exercise Price</b></font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Aggregate Intrinsic Value</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 46%"><font style="font-size: 8pt">Balance at December 31, 2018</font></td> <td style="width: 5%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 8pt">975,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 5%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 8pt">.11</font></td> <td style="width: 1%">&#160;</td> <td style="width: 5%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">Issued</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 8pt">Expired</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">Balance at March 31, 2019</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">975,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">.11</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Note 6 &#8211; Stockholders&#8217; Equity (Deficit)</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><i>Warrants</i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">A summary of warrants issued, exercised and expired during the three months ended March 31, 2019 is as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Shares</b></font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Weighted Average Exercise Price</b></font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Aggregate Intrinsic Value</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 46%"><font style="font-size: 8pt">Balance at December 31, 2018</font></td> <td style="width: 5%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 8pt">975,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 5%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 8pt">.11</font></td> <td style="width: 1%">&#160;</td> <td style="width: 5%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">Issued</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 8pt">Expired</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">Balance at March 31, 2019</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">975,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">.11</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">&#8212;</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> EX-101.SCH 7 pwvi-20190331.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Changes in Stockholders' Equity (Deficit) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Condensed Consolidated Financial Statements link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Intellectual Property and License Agreement link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Stockholders' Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stock Options link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Notes Payable to Related Parties link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Intellectual Property and License Agreement (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Stockholders' Equity (Deficit) (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Stock Options (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Intellectual Property and License Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Intellectual Property and License Agreement (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Stockholders' Equity (Deficit) (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Stock Options (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Notes Payable to Related Parties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 pwvi-20190331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 pwvi-20190331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 pwvi-20190331_lab.xml XBRL LABEL FILE Option Indexed to Issuer's Equity, Type [Axis] Employee Stock Option [Member] Equity Components [Axis] Additional Paid in Capital Accumulated Deficit Award Type [Axis] Warrants Option Related Party [Axis] Helidyne LLC [Member] Common Stock Additional Paid-In Capital Treasury Stock Preferred Stock Subsequent Event Type [Axis] Subsequent Event [Member] Document and Entity Information: Entity Registrant Name Document Type Document Period End Date Amendment Flag Entity Central Index Key Current Fiscal Year End Date Entity Common Stock, Shares Outstanding Entity Filer Category Entity Emerging Growth Company Entity Small Business Entity Current Reporting Status Entity Voluntary Filers Entity Well-known Seasoned Issuer Document Fiscal Year Focus Document Fiscal Period Focus Statement of Financial Position [Abstract] Assets Current Assets: Cash and cash equivalents Accounts receivable Prepaid expenses and other current assets Total Current Assets Property and Equipment Property and equipment, net of accumulated depreciation of $107,641 and $107,007, respectively Other Assets License, net of accumulated amortization of $28,322 and $25,822, respectively Total Other Assets Total Assets Liabilities and Stockholders' (Deficit) Equity Current Liabilities Accounts payable and accrued expenses Total Current Liabilities Long Term Liabilities Note Payable to related parties, net of loan costs Total Long Term Liabilities Total Liabilities Stockholders' Equity (Deficit) Preferred stock: 50,000,000 preferred shares authorized, 0 preferred shares issued at March 31, 2019 and December 31, 2018 Common stock: 200,000,000 common shares authorized, par value $0.0001 per share, 40,300,106 common shares issued and 31,750,106 shares outstanding at March 31, 2019 and December 31, 2018 Additional paid-in capital Treasury stock, 8,550,000 shares at cost Accumulated deficit Total Stockholders (Deficit) Equity Total Liabilities and Stockholders' Equity (Deficit) Assets [Abstract] Property and equipment, net of accumulated depreciation License, net of accumulated amortization Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common Stock, par value Common Stock, shares authorized Common Stock, shares issued Common Stock, shares outstanding Treasury stock Revenues [Abstract] Revenue Operating Expenses Research and development General and administrative Total Operating Expenses (Loss) Income from Operations Other Income (Expenses) Interest income Interest expense Total Other (Expense) Income (Loss) Income before Income Taxes Provision for Income Taxes Net (Loss) Income Net (Loss) Income per Share - Basic and Diluted Weighted Average Common Shares Outstanding - Basic and Diluted Statement [Table] Statement [Line Items] Balance Balance, Shares Net income (loss) Balance Balance, Shares Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows from Operating Activities Net (Loss) income Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities: Depreciation and amortization Changes in operating assets and liabilities Accounts receivable, prepaid expenses and other assets Accounts payable and accrued expenses Cash (Used) Provided by Operating Activities Cash Flows from Financing Activities Proceeds from notes payable, related party Payments for debt issuance costs Payment on notes payable, related party Cash Provided by (used in) Financing Activities Net Change in Cash and Cash Equivalents Cash and cash equivalents at Beginning of Period Cash and cash equivalents at End of Period Supplemental Disclosure of Cash Flow Information Cash paid during the period for interest Financial Statements Condensed Consolidated Financial Statements Going Concern: Going Concern Policy Text Block [Abstract] Summary of Significant Accounting Policies Recent Accounting Prouncements Recent Accounting Pronouncements Business Combinations [Abstract] Intellectual Property and License Agreement Equity: Stockholders’ Equity (Deficit) Stock Options Stock Options Notes Payable to Related Parties Notes Payable to Related Parties Commitment and Contingencies: Commitments and Contingencies Related Party Transactions Related Party Transactions Subsequent Events [Abstract] Subsequent Events Nature of Business Cash Equivalents Accounts Receivables Revenue Recognition Property and Equipment Impairment of Long-Lived Assets Stock-based Compensation Common Stock Purchase Warrants Accounting for Uncertainty in Income Taxes Research and Development Costs Earnings (Loss) Per Share Financial instruments Use of Estimates Future amortization of the intangible asset Summary of warrants Stock Option Going Concern Details Narrative Working capital deficit Revenue percentage Impairment losses Research and development cost Antidilutive Excluded from Computation of Earnings Per Share, Amount Intellectual Property Details Year ending December 31: 2019 2020 2021 Thereafter Total Business Acquisition [Axis] Amortization expense Accumulated amortization of the intangible asset- intellectual property Promissory note down payment Promissory note due Promissory note due date Commercial royalty obligation Annual royalty Warrants term Balance at beginning Shares Issued Shares Expired Balance at end Weighted Average Exercise Price Balance at beginning Weighted Average Exercise Price Issued Weighted Average Exercise Price Expired Weighted Average Exercise Price Balance at end Aggregate Intrinsic Value Balance at beginning Aggregate Intrinsic Value Issued Aggregate Intrinsic Value Expired Aggregate Intrinsic Value Balance at end Shares Begining Balance Granted Expired/forfeited Ending Balance Weighted Average Exercise Price Options Outstanding, Begining Balance, Weighted Average Exercise Price Granted Expired/forfeited Options Outstanding, Ending Balance, Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Options outstanding Begining Options outstanding Ending Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Stock-based compensation expense Unrecognized stock-based compensation Notes Payable To Related Parties Notes payable to stockholders Maturity date Interest rate Notes payable description Royalty percentage Company made payments Two monthly installments Committed to purchase price Revenue from product Payments to related party Subsequent Event, Description Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Promissory note down payment. Custom Element. Custom Element. Commercial royalty obligation. Custom Element. Custom Element. Revenue from product. Assets, Current Other Assets [Default Label] Assets [Default Label] Liabilities, Current Liabilities, Noncurrent Liabilities Treasury Stock, Value Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses [Default Label] Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Increase (Decrease) in Accounts Receivable and Other Operating Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments of Debt Issuance Costs Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents, at Carrying Value Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Mortgage Notes Payable Disclosure [Text Block] Related Party Transactions Disclosure [Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Finite-Lived Intangible Assets, Net Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price EX-101.PRE 11 pwvi-20190331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.19.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2019
May 14, 2019
Document and Entity Information:    
Entity Registrant Name POWERVERDE, INC.  
Document Type 10-Q  
Document Period End Date Mar. 31, 2019  
Amendment Flag false  
Entity Central Index Key 0000933972  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   31,750,106
Entity Filer Category Non-accelerated Filer  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity Current Reporting Status Yes  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q1  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 218,143 $ 8,482
Accounts receivable 5,000 10,000
Prepaid expenses and other current assets 15,574 10,866
Total Current Assets 238,717 29,348
Property and Equipment    
Property and equipment, net of accumulated depreciation of $107,641 and $107,007, respectively 0 634
Other Assets    
License, net of accumulated amortization of $28,322 and $25,822, respectively 71,678 74,178
Total Other Assets 71,678 74,178
Total Assets 310,395 104,160
Current Liabilities    
Accounts payable and accrued expenses 72,801 39,136
Total Current Liabilities 72,801 39,136
Long Term Liabilities    
Note Payable to related parties, net of loan costs 267,721 0
Total Long Term Liabilities 267,721 0
Total Liabilities 340,522 39,136
Stockholders' Equity (Deficit)    
Preferred stock: 50,000,000 preferred shares authorized, 0 preferred shares issued at March 31, 2019 and December 31, 2018 0 0
Common stock: 200,000,000 common shares authorized, par value $0.0001 per share, 40,300,106 common shares issued and 31,750,106 shares outstanding at March 31, 2019 and December 31, 2018 3,981 3,981
Additional paid-in capital 12,609,980 12,609,980
Treasury stock, 8,550,000 shares at cost (491,139) (491,139)
Accumulated deficit (12,152,949) (12,057,798)
Total Stockholders (Deficit) Equity (30,127) 65,024
Total Liabilities and Stockholders' Equity (Deficit) $ 310,395 $ 104,160
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Assets    
Property and equipment, net of accumulated depreciation $ 107,641 $ 107,007
License, net of accumulated amortization $ 28,322 $ 25,822
Preferred stock, shares authorized 50,000,000 50,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common Stock, par value $ 0.0001 $ 0.0001
Common Stock, shares authorized 200,000,000 200,000,000
Common Stock, shares issued 40,300,106 40,300,106
Common Stock, shares outstanding 31,750,106 31,750,106
Treasury stock 8,550,000 8,550,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenues [Abstract]    
Revenue $ 5,000 $ 162,094
Operating Expenses    
Research and development 35,059 35,292
General and administrative 60,798 70,394
Total Operating Expenses 95,857 105,686
(Loss) Income from Operations (90,857) 56,408
Other Income (Expenses)    
Interest income 0 914
Interest expense (4,294) (698)
Total Other (Expense) Income (4,294) 216
(Loss) Income before Income Taxes (95,151) 56,624
Provision for Income Taxes 0 0
Net (Loss) Income $ (95,151) $ 56,624
Net (Loss) Income per Share - Basic and Diluted $ 0 $ 0
Weighted Average Common Shares Outstanding - Basic and Diluted 31,750,106 31,750,106
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Treasury Stock
Total
Balance at Dec. 31, 2017 $ 3,981 $ 12,129,331 $ (11,378,720) $ (491,139) $ 263,453
Net income (loss)       56,624   56,624
Balance at Mar. 31, 2018   3,981 12,129,331 (11,322,096) (491,139) 320,077
Balance at Dec. 31, 2018 3,981 12,609,980 (12,057,798) (491,139) 65,024
Net income (loss)       (95,151)   (95,151)
Balance at Mar. 31, 2019   $ 3,981 $ 12,609,980 $ (12,152,949) $ (491,139) $ (30,127)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash Flows from Operating Activities    
Net (Loss) income $ (95,151) $ 56,624
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:    
Depreciation and amortization 4,054 8,440
Changes in operating assets and liabilities    
Accounts receivable, prepaid expenses and other assets 292 200,400
Accounts payable and accrued expenses 33,665 (81,315)
Cash (Used) Provided by Operating Activities (57,140) 184,149
Cash Flows from Financing Activities    
Proceeds from notes payable, related party 290,000 0
Payments for debt issuance costs (22,279) 0
Payment on notes payable, related party 0 (150,000)
Cash Provided by (used in) Financing Activities 267,721 (150,000)
Net Change in Cash and Cash Equivalents 209,661 34,149
Cash and cash equivalents at Beginning of Period 8,482 1,336
Cash and cash equivalents at End of Period 218,143 35,485
Supplemental Disclosure of Cash Flow Information    
Cash paid during the period for interest $ 0 $ 698
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Financial Statements
3 Months Ended
Mar. 31, 2019
Financial Statements  
Condensed Consolidated Financial Statements

Note 1 – Condensed Consolidated Financial Statements

 

The accompanying unaudited condensed consolidated financial statements prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report of PowerVerde, Inc. (“PowerVerde,” “we,” “us,” “our,” or the “Company”) as of and for the year ended December 31, 2018. The results of operations for the three months ended March 31, 2019, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of PowerVerde, Inc., formerly known as Vyrex Corporation (the “Company”), and PowerVerde Systems, Inc., formerly known as PowerVerde, Inc., its wholly-owned subsidiary. Intercompany balances and transactions have been eliminated in consolidation.

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Going Concern
3 Months Ended
Mar. 31, 2019
Going Concern:  
Going Concern

Note 2 – Going Concern

 

We have financed our operations since inception through the sale of debt and equity securities and through Biotech IP licensing revenues which expired in March 2018. As of March 31, 2019, we had working capital of $165,916 compared to working capital deficit of $9,788 at December 31, 2018. This improvement in working capital is due primarily to the sale of related party notes payable during this period.

 

The Company has historically relied upon unrelated and related party debt and equity financing to fund its cash flow shortages and will require either additional debt or equity financing to sustain its operations. The Company’s revenues through 2018 were derived mainly from royalties under its biotech licensing agreement, which expired in March 2018. Those factors create substantial doubt about the Company’s ability to continue as a going concern.

 

The Company continues to seek funding from private debt and equity investors, as it needs to promptly raise substantial additional capital in order to finance its plan of operations. There can be no assurance that the Company will be able to promptly raise the necessary additional funds on commercially acceptable terms, if at all. If the Company does not raise the necessary funds, it may be forced to cease operations.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2019
Policy Text Block [Abstract]  
Summary of Significant Accounting Policies

Note 3 – Summary of Significant Accounting Policies

 

Nature of Business

 

The Company is devoting substantially all of its present efforts to establish a new business involving the development and commercialization of clean energy electric power generation systems, and none of its planned principal operations have commenced. However, royalties from licenses unrelated to planned principal operations were recognized as revenue through March 2018, when the underlying license agreement terminated. No material revenues from this planned principal operation have been generated.

 

Cash Equivalents

 

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. 

 

Accounts Receivable

 

Accounts receivable consist of balances due from assembly services. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2019, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.

 

Revenue Recognition

 

Royalties are recognized as earned in the period the sales to which the royalties relate occur. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer. Revenues recognized under these agreements amount to 100% of total revenues for the three months ended March 31, 2019 and 2018.

 

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.

 

Impairment of Long-Lived Assets

 

Impairment losses are recorded on long-lived assets (property, equipment and intellectual property) used in operations when impairment indicators are present and the undiscounted expected cash flows estimated to be generated by those assets are less than the carrying value of such assets. No impairment losses have been recognized during the three months ended March 31, 2019 or 2018.

 

Stock-based Compensation

 

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

 

Common Stock Purchase Warrants

 

The Company accounts for common stock purchase warrants in accordance with ASC Topic 815- 40, “Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASC 815-40”). Based on the provisions of ASC 815- 40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company, or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of December 31, 2018 and March 31, 2019 were classified as equity.

 

Accounting for Uncertainty in Income Taxes

 

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements, and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

 

Research and Development Costs

 

The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $35,059 and $35,292 for the three months ended March 31, 2019 and 2018, respectively.

 

Earnings (Loss) Per Share

 

Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. Warrants exercisable for 3,675,000 shares and options for 5,750,500 shares were excluded from weighted average common shares outstanding on a diluted basis.

 

Financial instruments

 

The Company carries cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and notes payable, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature or market interest rates on interest bearing debt.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Recent Accounting Pronouncements
3 Months Ended
Mar. 31, 2019
Recent Accounting Prouncements  
Recent Accounting Pronouncements

Note 4 – Recent Accounting Pronouncements

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”). Topic 606 supersedes the revenue recognition requirements in ASU Topic 605, Revenue Recognition (“Topic 605”), and requires the recognition of revenue when promised goods or services are transferred to customers in an amount that reflects the considerations to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 also includes Subtopic 340-40, Other Assets and Deferred Costs- Contracts with Customers, which discussed the deferral of incremental costs of obtaining a contract with a customer, including the period of amortization of such costs. The new standard was adopted by the Company in our fiscal year beginning January 1, 2018. The impact of adoption of the new standard on our revenue recognition was not significant; accordingly, there was no cumulative effect adjustment of adoption on January 1, 2018 retained earnings.

 

We have reviewed each of our current contracts for the related performance obligations and related revenue and expense recognition implications. A performance obligation under the new revenue standard is defined as a promise to provide a “distinct” good or service to a customer. The Company has determined that the assembly services is a performance obligation for which a transaction price has been established in the manufacturing agreement. The assembly of each unit stands on its own. Revenue related to assembly services is recognized as revenue when the assembled product is delivered to the customer. The Company has also determined that the performance obligation associated with our royalty revenues was the ongoing delivery of the license to which the royalties relate. Royalty revenues were recognized based on the contract royalty rate applied to licensee sales in the periods during which such sales occurred.

 

In February 2016, the FASB issued ASU 2016-02, “Leases,” which created a new Topic, ASC Topic 842 and established the core principle that a lessee should recognize the assets, representing rights-of-use, and liabilities to make lease payments that arise from leases. For leases with a term of 12 months or less, a lessee is permitted to make an election under which such assets and liabilities would not be recognized, and lease expense would be recognized generally on a straight-line basis over the lease term. This ASU is effective for public entities for interim and annual reporting periods beginning after December 15, 2018. The Company adopted ASU Topic 842 on January 1, 2019 and such adoption did not have any impact on the Company’s financial statements.

 

In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718).” ASU 2018-07 simplifies the accounting for nonemployee stock-based payment transactions. This ASU is effective for public entities for interim and annual reporting periods beginning after December 15, 2018, and early application is permitted. The adoption of this guidance on January 1, 2019 did not have an impact on the Company’s financial statements.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Intellectual Property and License Agreement
3 Months Ended
Mar. 31, 2019
Business Combinations [Abstract]  
Intellectual Property and License Agreement

Note 5 – Intellectual Property and License Agreement

 

On June 30, 2015, the Company entered into an Assignment Agreement with VyrexIP Holdings Inc., a company owned by Company shareholder Edward Gomez, for the purchase of intellectual property. The net price of these assets was comprised of a down payment of $16,116 and a $58,436 promissory note to the seller due July 15, 2016, partially offset by assignment by the seller to the Company of a $38,000 promissory note due November 14, 2015, issued by the seller’s licensee Epalex Corporation, a company of which Mr. Gomez is chairman and a major stockholder. This note was paid in full in November 2015. Accumulated amortization with respect to this intellectual property was $74,178 and $71,678 at March 31, 2019 and December 31, 2018, respectively.

 

On June 1, 2016, the Company entered into a ten-year License Agreement with Helidyne LLC for total consideration of $100,000 to utilize the Helidyne intellectual property in the manufacturing of planetary rotor expanders and the incorporation of same in the Company’s distributed electric power generation systems. The license agreement also grants the Company an exclusive license to sell the expanders whether manufactured by Helidyne or by the Company. The Company’s royalty obligation begins on the earlier of the commercialization of the product or three years from the effective date of the agreement. Once the royalty obligation begins, the minimum annual royalty is $50,000 for each of the first six years, and $100,000, per commercial year, for the remainder of the agreement.

 

For the three months ended March 31, 2019 and 2018, amortization expense was $2,500 and $4,874 respectively, and accumulated amortization of the intangible assets was $28,322 and $25,822 at March 31, 2019 and December 31, 2018, respectively.

 

Future amortization of the intangible assets is as follows as of March 31, 2019:

 

Year ending December 31:    
2019   $ 7,500  
2020     10,000  
2021     10,000  
Thereafter     44,178  
Total   $ 71,678  
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity (Deficit)
3 Months Ended
Mar. 31, 2019
Equity:  
Stockholders’ Equity (Deficit)

Note 6 – Stockholders’ Equity (Deficit)

 

Warrants

 

A summary of warrants issued, exercised and expired during the three months ended March 31, 2019 is as follows:

 

    Shares   Weighted Average Exercise Price   Aggregate Intrinsic Value
Balance at December 31, 2018     975,000     $ .11     $  
Issued                  
Expired                  
Balance at March 31, 2019     975,000     $ .11     $  
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Options
3 Months Ended
Mar. 31, 2019
Stock Options  
Stock Options

Note 7 – Stock Options

 

Stock option activity for the quarter ended March 31, 2019, is summarized as follows:

 

    Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2018     11,180,500     $ 0.20       7.02  
Granted                  
Expired/forfeited                  
Options outstanding at March 31, 2019     11,180,500     $ 0.20       6.27  

 

Total stock option compensation for the three months ended March 31, 2019 and 2018 was $0. There is no unrecognized compensation expense associated with the options.

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Notes Payable to Related Parties
3 Months Ended
Mar. 31, 2019
Notes Payable to Related Parties  
Notes Payable to Related Parties

Note 8 – Notes Payable to Related Parties

 

In the first quarter of 2019, the Company issued Series B Convertible Promissory Notes totaling $290,000 to stockholders. The notes are to be paid in one principal payment, along with any unpaid interest, by December 31, 2021. Interest is payable semiannually at 10%. The notes are convertible into common stock at a price of $.20 per share through December 31, 2019, $.30 per share from January 1, 2020 through December 31, 2020, and $.40 per share from January 1, 2021 through the maturity date of December 31, 2021.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2019
Commitment and Contingencies:  
Commitments and Contingencies

Note 9 - Commitments and Contingencies

 

On June 25, 2015, Company consultant Hank Leibowitz assigned to the Company a patent he obtained for a system and method for using high temperature sources in Rankine cycle power systems. The Company has agreed to pay Mr. Leibowitz a 2% royalty for any and all revenues of products and/or project sales by the Company based on the subject patent.

 

On June 1, 2016, the Company entered into a ten-year License Agreement with Helidyne LLC to utilize the Helidyne intellectual property in order to use Helidyne expanders in Powerverde systems and to sell Helidyne expanders. As part of the licensing agreement the Company committed to purchase two 50 kW expanders, at a price of $25,000 each, on or before the sixth month anniversary of the agreement. The $50,000 was payable in two monthly installments of $25,000 beginning October 2016. The Company had made payments totaling $38,750, towards the purchase of the expanders. Due to Helidyne’s failure to perform under the agreement, the Company has not made any further payments to Helidyne and does not intend to do so unless and until Helidyne performs as required. Helidyne has not objected to the Company’s position, and it is very unlikely that Helidyne will ever be able to perform.

 

The Company agreed to pay Helidyne LLC a royalty of 3% of sales, subject to a minimum annual royalty of $50,000 beginning on the earlier of commercialization of the product or three years from the effective date of the agreement. This minimum royalty would be payable only if Helidyne performs as required, which is very unlikely, or if the Company elects to produce its own expanders using Helidyne technology. The Company does intend to produce these expanders directly or through a contract manufacturer in the future. See Note 5.

 

On April 15, 2017, the Company entered into an assembly agreement with Liberty Plugins, Inc. (“Liberty”) to assemble Liberty’s Hydra electronic vehicle charging systems and ship completed Hydras to Liberty’s facility in Santa Barbara, California (the “Liberty Agreement”). Liberty has agreed to pay $1,000 for the first 10 Hydras assembled in a month, $750 per Hydra for the next 10 Hydras assembled per month and $500 per Hydra for each Hydra assembled above 20 per month. The Company has never assembled/shipped more than 10 Hydras in any month and does not expect to do so in the future. As of March 31, 2019, the Company has built and shipped 70 Hydras. Revenue of $5,000 and $3,000 for these products is reflected in the net revenue on the Company’s condensed consolidated statements of operations for the three months ended March 31, 2019 and 2018, respectively.

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Related Party Transactions
3 Months Ended
Mar. 31, 2019
Related Party Transactions  
Related Party Transactions

Note 10 - Related Party Transactions

 

Since July 2010, the accounting firm J.L. Hofmann & Associates, P.A. (“JLHPA”), whose principal is our CFO John L. Hofmann, has provided financial consulting and accounting services to the Company. In December 2017, J.L. Hofmann & Associates, P.A. merged with Kabat, Schertzer, De La Torre, Taraboulos & Co, LLC (“KSDT”). The Company paid $9,614 and $10,730 for its services in the three months ended March 31, 2019 and 2018, respectively.

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events
3 Months Ended
Mar. 31, 2019
Subsequent Events [Abstract]  
Subsequent Events

Note 11 – Subsequent Events

 

The Company’s management evaluated subsequent events through May 10, 2019, in connection with the preparation of these condensed consolidated financial statements, which is the date these financial statements were available to be issued. There are no subsequent events to report as of this date, except that in May 2019 the Company issued a Series B Convertible Promissory Note in the principal amount of $10,000 to a stockholder in connection with a loan in the same amount. Consequently, Series B Convertible Promissory Notes have been issued in an aggregate principal amount of $300,000 during the first two quarters of 2019. See Note 8.

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2019
Policy Text Block [Abstract]  
Nature of Business

Nature of Business

 

The Company is devoting substantially all of its present efforts to establish a new business involving the development and commercialization of clean energy electric power generation systems, and none of its planned principal operations have commenced. However, royalties from licenses unrelated to planned principal operations were recognized as revenue through March 2018, when the underlying license agreement terminated. No material revenues from this planned principal operation have been generated.

Cash Equivalents

Cash Equivalents

 

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.

Accounts Receivables

Accounts Receivable

 

Accounts receivable consist of balances due from assembly services. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2019, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.

Revenue Recognition

Revenue Recognition

 

Royalties are recognized as earned in the period the sales to which the royalties relate occur. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer. Revenues recognized under these agreements amount to 100% of total revenues for the three months ended March 31, 2019 and 2018.

Property and Equipment

Property and Equipment

 

Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

Impairment losses are recorded on long-lived assets (property, equipment and intellectual property) used in operations when impairment indicators are present and the undiscounted expected cash flows estimated to be generated by those assets are less than the carrying value of such assets. No impairment losses have been recognized during the three months ended March 31, 2019 or 2018.

Stock-based Compensation

Stock-based Compensation

 

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

Common Stock Purchase Warrants

Common Stock Purchase Warrants

 

The Company accounts for common stock purchase warrants in accordance with ASC Topic 815- 40, “Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASC 815-40”). Based on the provisions of ASC 815- 40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company, or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of December 31, 2018 and March 31, 2019 were classified as equity.

Accounting for Uncertainty in Income Taxes

Accounting for Uncertainty in Income Taxes

 

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements, and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

Research and Development Costs

Research and Development Costs

 

The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $35,059 and $35,292 for the three months ended March 31, 2019 and 2018, respectively.

Earnings (Loss) Per Share

Earnings (Loss) Per Share

 

Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. Warrants exercisable for 3,675,000 shares and options for 5,750,500 shares were excluded from weighted average common shares outstanding on a diluted basis.

Financial instruments

Financial instruments

 

The Company carries cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and notes payable, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature or market interest rates on interest bearing debt.

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Intellectual Property and License Agreement (Tables)
3 Months Ended
Mar. 31, 2019
Business Combinations [Abstract]  
Future amortization of the intangible asset

Future amortization of the intangible assets is as follows as of March 31, 2019:

 

Year ending December 31:    
2019   $ 7,500  
2020     10,000  
2021     10,000  
Thereafter     44,178  
Total   $ 71,678  
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity (Deficit) (Tables)
3 Months Ended
Mar. 31, 2019
Equity:  
Summary of warrants

A summary of warrants issued, exercised and expired during the three months ended March 31, 2019 is as follows:

 

    Shares   Weighted Average Exercise Price   Aggregate Intrinsic Value
Balance at December 31, 2018     975,000     $ .11     $  
Issued                  
Expired                  
Balance at March 31, 2019     975,000     $ .11     $  
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Options (Tables)
3 Months Ended
Mar. 31, 2019
Stock Options  
Stock Option

Stock option activity for the quarter ended March 31, 2019, is summarized as follows:

 

    Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2018     11,180,500     $ 0.20       7.02  
Granted                  
Expired/forfeited                  
Options outstanding at March 31, 2019     11,180,500     $ 0.20       6.27  
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Going Concern (Details Narrative) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Going Concern Details Narrative    
Working capital deficit $ 165,916 $ (9,788)
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenue percentage 100.00% 100.00%
Impairment losses $ 0 $ 0
Research and development cost $ 35,059 $ 35,292
Warrants    
Antidilutive Excluded from Computation of Earnings Per Share, Amount 3,675,000  
Option    
Antidilutive Excluded from Computation of Earnings Per Share, Amount 5,750,500  
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Intellectual Property and License Agreement (Details)
Mar. 31, 2019
USD ($)
Year ending December 31:  
2019 $ 7,500
2020 10,000
2021 10,000
Thereafter 44,178
Total $ 71,678
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Intellectual Property and License Agreement (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Jun. 02, 2016
Jun. 30, 2015
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Jun. 01, 2016
Amortization expense     $ 2,500 $ 4,874    
Accumulated amortization of the intangible asset- intellectual property     $ 28,322   $ 25,822  
Promissory note down payment   $ 16,116        
Promissory note due   $ 58,436     $ 38,000  
Promissory note due date   Jul. 15, 2016 Nov. 14, 2015      
Helidyne LLC [Member]            
Commercial royalty obligation $ 100,000          
Annual royalty           $ 50,000
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity (Deficit) (Details)
3 Months Ended
Mar. 31, 2019
$ / shares
shares
Warrants term  
Balance at beginning | shares 975,000
Shares Issued | shares
Shares Expired | shares
Balance at end | shares 975,000
Weighted Average Exercise Price Balance at beginning $ 0.11
Weighted Average Exercise Price Issued
Weighted Average Exercise Price Expired
Weighted Average Exercise Price Balance at end 0.11
Aggregate Intrinsic Value Balance at beginning
Aggregate Intrinsic Value Issued
Aggregate Intrinsic Value Expired
Aggregate Intrinsic Value Balance at end
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Options (Details)
3 Months Ended
Mar. 31, 2019
$ / shares
shares
Shares  
Granted
Expired/forfeited
Employee Stock Option [Member]  
Shares  
Begining Balance 11,180,500
Granted
Expired/forfeited
Ending Balance 11,180,500
Weighted Average Exercise Price  
Options Outstanding, Begining Balance, Weighted Average Exercise Price | $ / shares $ 0.2
Granted | $ / shares
Expired/forfeited | $ / shares
Options Outstanding, Ending Balance, Weighted Average Exercise Price | $ / shares $ 0.2
Weighted Average Remaining Contractual Life (Years)  
Options outstanding Begining 7 years 7 days
Options outstanding Ending 6 years 3 months 8 days
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Options (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Stock-based compensation expense $ 0 $ 0
Unrecognized stock-based compensation $ 0  
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Notes Payable to Related Parties (Details Narrative)
3 Months Ended
Mar. 31, 2019
USD ($)
Notes Payable To Related Parties  
Notes payable to stockholders $ 290,000
Maturity date Dec. 31, 2021
Interest rate 10.00%
Notes payable description The notes are convertible into common stock at a price of $.20 per share through December 31, 2019, $.30 per share from January 1, 2020 through December 31, 2020, and $.40 per share from January 1, 2021 through the maturity date of December 31, 2021.
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Oct. 01, 2016
Jun. 01, 2016
Jun. 25, 2015
Royalty percentage         2.00%
Company made payments $ 38,750        
Two monthly installments     $ 25,000    
Revenue from product $ 5,000 $ 3,000      
Helidyne LLC [Member]          
Royalty percentage       3.00%  
Annual royalty       $ 50,000  
Two monthly installments       50,000  
Committed to purchase price       $ 25,000  
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Related Party Transactions    
Payments to related party $ 9,614 $ 10,730
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events (Details Narrative)
May 14, 2019
Subsequent Event [Member]  
Subsequent Event, Description Company issued a Series B Convertible Promissory Note in the principal amount of $10,000 to a stockholder in connection with a loan in the same amount. Consequently, Series B Convertible Promissory Notes have been issued in an aggregate principal amount of $300,000 during the first two quarters of 2019.
EXCEL 44 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 46 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 47 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 39 139 1 false 10 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://pwvi.com/20131231/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://pwvi.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://pwvi.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://pwvi.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Changes in Stockholders' Equity (Deficit) (Unaudited) Sheet http://pwvi.com/role/ChangesInStockholdersEquityDeficit Condensed Consolidated Changes in Stockholders' Equity (Deficit) (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://pwvi.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Condensed Consolidated Financial Statements Sheet http://pwvi.com/role/FinancialStatements Condensed Consolidated Financial Statements Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern Sheet http://pwvi.com/role/GoingConcern Going Concern Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://pwvi.com/20131231/role/idr_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Recent Accounting Pronouncements Sheet http://pwvi.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 10 false false R11.htm 00000011 - Disclosure - Intellectual Property and License Agreement Sheet http://pwvi.com/role/IntellectualProperty Intellectual Property and License Agreement Notes 11 false false R12.htm 00000012 - Disclosure - Stockholders' Equity (Deficit) Sheet http://pwvi.com/role/StockholdersEquityDeficit Stockholders' Equity (Deficit) Notes 12 false false R13.htm 00000013 - Disclosure - Stock Options Sheet http://pwvi.com/20131231/role/idr_DisclosureStockOptions Stock Options Notes 13 false false R14.htm 00000014 - Disclosure - Notes Payable to Related Parties Notes http://pwvi.com/20131231/role/idr_DisclosureNotesPayableToRelatedParties Notes Payable to Related Parties Notes 14 false false R15.htm 00000015 - Disclosure - Commitments and Contingencies Sheet http://pwvi.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 00000016 - Disclosure - Related Party Transactions Sheet http://pwvi.com/20131231/role/idr_DisclosureRelatedPartyTransactions Related Party Transactions Notes 16 false false R17.htm 00000017 - Disclosure - Subsequent Events Sheet http://pwvi.com/20131231/role/idr_DisclosureSubsequentEvents Subsequent Events Notes 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://pwvi.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://pwvi.com/20131231/role/idr_DisclosureSummaryOfSignificantAccountingPolicies 18 false false R19.htm 00000019 - Disclosure - Intellectual Property and License Agreement (Tables) Sheet http://pwvi.com/role/IntellectualPropertyTables Intellectual Property and License Agreement (Tables) Tables http://pwvi.com/role/IntellectualProperty 19 false false R20.htm 00000020 - Disclosure - Stockholders' Equity (Deficit) (Tables) Sheet http://pwvi.com/role/StockholdersEquityDeficitTables Stockholders' Equity (Deficit) (Tables) Tables http://pwvi.com/role/StockholdersEquityDeficit 20 false false R21.htm 00000021 - Disclosure - Stock Options (Tables) Sheet http://pwvi.com/role/StockOptionsTables Stock Options (Tables) Tables http://pwvi.com/20131231/role/idr_DisclosureStockOptions 21 false false R22.htm 00000022 - Disclosure - Going Concern (Details Narrative) Sheet http://pwvi.com/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://pwvi.com/role/GoingConcern 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://pwvi.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details Narrative) Details http://pwvi.com/role/SummaryOfSignificantAccountingPoliciesPolicies 23 false false R24.htm 00000024 - Disclosure - Intellectual Property and License Agreement (Details) Sheet http://pwvi.com/role/IntellectualPropertyAndLicenseAgreementDetails Intellectual Property and License Agreement (Details) Details http://pwvi.com/role/IntellectualPropertyTables 24 false false R25.htm 00000025 - Disclosure - Intellectual Property and License Agreement (Details Narrative) Sheet http://pwvi.com/role/IntellectualPropertyAndLicenseAgreementDetailsNarrative Intellectual Property and License Agreement (Details Narrative) Details http://pwvi.com/role/IntellectualPropertyTables 25 false false R26.htm 00000026 - Disclosure - Stockholders' Equity (Deficit) (Details) Sheet http://pwvi.com/role/StockholdersEquityDeficitDetails Stockholders' Equity (Deficit) (Details) Details http://pwvi.com/role/StockholdersEquityDeficitTables 26 false false R27.htm 00000027 - Disclosure - Stock Options (Details) Sheet http://pwvi.com/role/StockOptionsStockOptionActivityDetails Stock Options (Details) Details http://pwvi.com/role/StockOptionsTables 27 false false R28.htm 00000028 - Disclosure - Stock Options (Details Narrative) Sheet http://pwvi.com/role/StockOptionsDetailsNarrative Stock Options (Details Narrative) Details http://pwvi.com/role/StockOptionsTables 28 false false R29.htm 00000029 - Disclosure - Notes Payable to Related Parties (Details Narrative) Notes http://pwvi.com/role/NotesPayableToRelatedPartiesDetailsNarrative Notes Payable to Related Parties (Details Narrative) Details http://pwvi.com/20131231/role/idr_DisclosureNotesPayableToRelatedParties 29 false false R30.htm 00000030 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://pwvi.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://pwvi.com/role/CommitmentsAndContingencies 30 false false R31.htm 00000031 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://pwvi.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://pwvi.com/20131231/role/idr_DisclosureRelatedPartyTransactions 31 false false R32.htm 00000032 - Disclosure - Subsequent Events (Details Narrative) Sheet http://pwvi.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://pwvi.com/20131231/role/idr_DisclosureSubsequentEvents 32 false false All Reports Book All Reports pwvi-20190331.xml pwvi-20190331.xsd pwvi-20190331_cal.xml pwvi-20190331_def.xml pwvi-20190331_lab.xml pwvi-20190331_pre.xml http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 49 0001575705-19-000060-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001575705-19-000060-xbrl.zip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

@J$^H3H['J?F>(CZ$=42VT93TH=NQUN@IX M2MF,!$GVG%FAX;R@V5KFX6P0\&FT\[J]%@D&S'Q6?9_/JA&9BR/5B&?4$6XD MOAP@.D4LM/8V^NME-W$2V6+Y=WJUW4DFB8UR?B.BP!U'[X$P=TZRY4SX1S8U M?C6F_TP\H/FV61_VC',6)1S'./"& MVK.T9P7M12@+=RU= ?V3[^"UZMO=#N(/"C4_:"]NC7%D0*"U:*\SB Y*KEU\ MVU8P@_Z_V5TL_K)R>404D_ M:-YD&;Y^U@]E]O//97E&DP91CE(F3#-?=8WRF'OXB@VYM&//M8JF_3),X<2.?GP6N M:1CR0Z;XXW"WV;+OC255=5A]OSB;&BPN3OXI[%EG8 L9S!Q?8^E''$L_7*;Q MF*P9%F4_TFK^KQ'Z@R9RC\G.V\3NC]AR,?<3!BY]O*>];++-1@V^!NDTJ*<2 MWK2^H[EB@4<$3K-G/(N!>;&_Q "B,9+_]"_C+5!>_[ 63$ZLH46@3RZF0 MG"8?G]=$1!/PWQ_1*!,\=<-;PA8'&@-\;F;P I2?U=KZS4GL /M I4.?7Z)# M23PO"B=0*[;V8M3(BM'4+#5AK#!ZV'-@/\*"Y[L^^-7/DK1E]')6AK9XVN"( MQDE<0Q:PO>E*%WN5K@TNTYT<>E19/\B"-FMV[;(VP9.$/?#32C/+F]R?;):* M;\5[A.6_"_5: M-*U6E!#GG#*_\JEAMQ5FT>4.2%6&;)/D=JP#XJ6+;?;G9S=)FJ# M6EFX/\#T:K$1/O$.*M=W??UXSRUXSRUW> C5%K\0XP)A@WMK$^(EO!MTX'&D@?\\-_B[?2 'P)P MA:_ZE++/;N3FUYNG1+'=E7; GI? $&E$'FB"$B=;-PPS0Y#,3;M-T/,T0?-2 MDUB66';*O'LW)ML!N+E]_\S_O4@7^7C,_YYL70 --F]."CV3$3P:VJIIJ(6< M/) H):=$AD\$.'VX#>SI7KJ*+);BH[4P/D%4U/RO\Z>I]2IJCN\)T=J9& MQ&UL4$L! A0#% @ C6ZO3D+5N_)R"@ V%L !$ ( ! M'-D4$L! A0#% @ C6ZO3LLC@SKX"@ M*7P !4 ( !$T, '!W=FDM,C Q.3 S,S%?8V%L+GAM;%!+ M 0(4 Q0 ( (UNKT[:JA1#J@T )J[ 5 " 3Y. !P M=W9I+3(P,3DP,S,Q7V1E9BYX;6Q02P$"% ,4 " "-;J].E0FR2-8L \ MAP( %0 @ $;7 <'=V:2TR,#$Y,#,S,5]L86(N>&UL4$L! M A0#% @ C6ZO3E.5-